Skip to main content
logo
Gland Pharma Limited (BOM:543245)
India flag India · Delayed Price · Currency is INR
1,970.75
+74.65 (3.94%)
At close: Jul 16, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192017 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2017 - 2018
Generic Injectibles
56.65B
Log In
Log In
Log In
Log In
Upgrade
Generic Injectibles Growth
56.29%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192017 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2017 - 2018
United States
26.88B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
28.54%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
11.82B
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
71.43%
Log In
Log In
Log In
Log In
Upgrade
Europe
10.53B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
462.62%
Log In
Log In
Log In
Log In
Upgrade
India
5.88B
Log In
Log In
Log In
Log In
Upgrade
India Growth
5.97%
Log In
Log In
Log In
Log In
Upgrade
Canada
890.27M
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
12.00%
Log In
Log In
Log In
Log In
Upgrade
Australia
626.45M
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
187.05%
Log In
Log In
Log In
Log In
Upgrade
New Zealand
28.17M
Log In
Log In
Log In
Log In
Upgrade
New Zealand Growth
159.39%
Log In
Log In
Log In
Log In
Upgrade